Patent details

Basic Information

Publication number:

EP2508188

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP121539399

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate

French Title of Invention:

Formulations pharmaceutiques contenant un hydrate de propylèneglycol dapagliflozine

German Title of Invention:

Pharmazeutische Formulierungen mit Dapagliflozin-Propylenglycol-Hydrat

SPC Number:

Dates

Filing date:

21/03/2008

Grant date:

10/05/2023

EP Publication Date:

10/10/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/05/2023

EP B1 Publication Date:

10/05/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

21/03/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/05/2023

 

 

Name:

AstraZeneca AB

Address:

Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Agent

Name:

ARONOVA S.A.

From:

07/07/2023

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

Tejwani, Ravindra W.

Address:

United States (US)

2

Name:

Vatsaraj, Nipa

Address:

United States (US)

3

Name:

Dali, Mandar V.

Address:

United States (US)

4

Name:

Wu, Yongmei

Address:

United States (US)

5

Name:

Bindra, Dilbir

Address:

United States (US)

6

Name:

Parab, Prakash V.

Address:

United States (US)

7

Name:

Patel, Jatin M.

Address:

United States (US)

8

Name:

Tao, Li

Address:

United States (US)

Priority

Priority Number:

896286 P

Priority Date:

22/03/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/70; A61P 3/10; A61K 9/16; A61K 9/20;

Publication

European Patent Bulletin

1

Issue number:

202319

Publication date:

10/05/2023

Description:

Grant (B1)

2

Issue number:

202323

Publication date:

07/06/2023

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

19

Annual Fee Amount:

281 Euro

Expected Payer:

Last Annual Fee Payment Date:

18/02/2025

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
06/07/2023	Power Of Attorney	1
07/07/2023	Outgoing Correspondence	1